Thakar, M., Logan, B. R., Puck, J., Dunn, E., Buckley, R., Cowan, M., … Notarangelo, L. (2023). Newborn screening has improved the survival of infants with severe combined immunodeficiency (SCID) – a Primary Immune Deficiency Treatment Consortium (PIDTC) study. In Clinical Immunology (Vol. 250, pp. 109350–109350). Elsevier BV. https://doi.org/10.1016/j.clim.2023.109350

Thakar, Monica, Brent R. Logan, Jennifer Puck, Elizabeth Dunn, Rebecca Buckley, Morton Cowan, Sung-Yun Pai, et al. “Newborn screening has improved the survival of infants with severe combined immunodeficiency (SCID) – a Primary Immune Deficiency Treatment Consortium (PIDTC) study.” In Clinical Immunology, 250:109350–109350. Elsevier BV, 2023. https://doi.org/10.1016/j.clim.2023.109350.

Thakar M, Logan BR, Puck J, Dunn E, Buckley R, Cowan M, et al. Newborn screening has improved the survival of infants with severe combined immunodeficiency (SCID) – a Primary Immune Deficiency Treatment Consortium (PIDTC) study. In: Clinical Immunology. Elsevier BV; 2023. p. 109350–109350.

Thakar, Monica, et al. “Newborn screening has improved the survival of infants with severe combined immunodeficiency (SCID) – a Primary Immune Deficiency Treatment Consortium (PIDTC) study.” Clinical Immunology, vol. 250, Elsevier BV, 2023, pp. 109350–109350. Crossref, doi:10.1016/j.clim.2023.109350.

Thakar M, Logan BR, Puck J, Dunn E, Buckley R, Cowan M, Pai S-Y, Heimall J, Pulsipher M, Griffith L, Haddad E, Dvorak CC, Notarangelo L. Newborn screening has improved the survival of infants with severe combined immunodeficiency (SCID) – a Primary Immune Deficiency Treatment Consortium (PIDTC) study. Clinical Immunology. Elsevier BV; 2023. p. 109350–109350.